Literature DB >> 22414241

Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: a systematic review.

Man Li1, Hao Zheng, Tao Li, Ping Gao, Xiao-Lin Zhang, Dian-Wu Liu.   

Abstract

BACKGROUND AND AIM: The cytotoxic T-lymphocyte antigen 4 (CTLA4) is an inhibitory receptor expressed on activated and regulatory T lymphocytes. Polymorphisms could have remarkable effects on susceptibility to autoimmunity. However, the associations between CTLA-4 polymorphisms and primary biliary cirrhosis (PBC) remain ambiguous. The aim of this meta-analysis is to determine more precise estimations of the relationship.
METHODS: From literature retrieval from PubMed, Web of Science, Science Direct, and the Chinese National Knowledge Infrastructure (CNKI) Database, the publications on the associations between rs231775, rs3087243, rs5742909, rs231725 and rs11571317 polymorphisms of CTLA4 and PBC through June 2011 were collected. Odds ratios (OR) with 95% confidence intervals (95% CI) were calculated in fixed or random model, I(2) was calculated to examine heterogeneity, and funnel plots were plotted to examine small study effects with Revman 5.1 and Stata 11.
RESULTS: Overall, a significantly increased risk was found for G versus A allele for rs231775 (OR = 1.28, 95% CI = 1.17-1.41). For rs3087243, a significant association was found for AA versus GG genotype (OR = 0.66; 95% CI = 0.55-0.80). When subgroup analysis by ethnicity was performed, the same association was only found in Caucasians. For rs231725, the OR values (95% CI) for GG versus AA, GA versus AA and G versus A allele were 0.52 (0.40-0.68), 0.74 (0.60-0.92) and 0.73 (0.61-0.88). No significant associations were found for other polymorphisms.
CONCLUSION: The G allele of rs231775 is a risk factor for PBC, while AA genotype of rs3087243 and GG, GA and G allele of rs231725 show negative associations with PBC.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414241     DOI: 10.1111/j.1440-1746.2012.07118.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

Review 1.  Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics.

Authors:  Amitkumar Patel; Anil Seetharam
Journal:  J Clin Exp Hepatol       Date:  2016-10-21

Review 2.  CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.

Authors:  Jia-Jun Zhao; Di Wang; Hui Yao; Da-Wei Sun; Hong-Yu Li
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

Review 3.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08

Review 4.  Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.

Authors:  Sherry-Ann Brown; Jordan C Ray; Joerg Herrmann
Journal:  J Cardiovasc Transl Res       Date:  2020-04-06       Impact factor: 4.132

5.  Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas.

Authors:  Changchun Fan; Xuechun Zhao; Zhixing Xu
Journal:  Tumour Biol       Date:  2014-09-18

6.  Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function.

Authors:  Louisa E Jeffery; Omar S Qureshi; David Gardner; Tie Z Hou; Zoe Briggs; Blagoje Soskic; Jennifer Baker; Karim Raza; David M Sansom
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

Review 7.  Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis.

Authors:  Xing-Chen Yang; Masayuki Fujino; Song-Jie Cai; Shao-Wei Li; Chi Liu; Xiao-Kang Li
Journal:  J Immunol Res       Date:  2017-05-31       Impact factor: 4.818

8.  Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis.

Authors:  Nina K Serwas; Birgit Hoeger; Rico C Ardy; Sigrun V Stulz; Zhenhua Sui; Nima Memaran; Marie Meeths; Ana Krolo; Özlem Yüce Petronczki; Laurène Pfajfer; Tie Z Hou; Neil Halliday; Elisangela Santos-Valente; Artem Kalinichenko; Alan Kennedy; Emily M Mace; Malini Mukherjee; Bianca Tesi; Anna Schrempf; Winfried F Pickl; Joanna I Loizou; Renate Kain; Bettina Bidmon-Fliegenschnee; Jean-Nicolas Schickel; Salomé Glauzy; Jakob Huemer; Wojciech Garncarz; Elisabeth Salzer; Iro Pierides; Ivan Bilic; Jens Thiel; Peter Priftakis; Pinaki P Banerjee; Elisabeth Förster-Waldl; David Medgyesi; Wolf-Dietrich Huber; Jordan S Orange; Eric Meffre; David M Sansom; Yenan T Bryceson; Amnon Altman; Kaan Boztug
Journal:  Nat Commun       Date:  2019-07-15       Impact factor: 17.694

9.  The role of vitamin d in primary biliary cirrhosis: possible genetic and cell signaling mechanisms.

Authors:  Khanh Vinh Quốc L Ng; Lan Thi Hoàng Nguyễn
Journal:  Gastroenterol Res Pract       Date:  2013-03-26       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.